Gadolinium based MRI contrast agents have been linked to the development of nephrogenic systemic fibrosis (NSF) in individuals with kidney insufficiencies. If the manufacturers of these contrast agents had properly conducted studies of their product or analyzed reports and other clinical data, they could have warned… Read More
Many individuals diagnosed with nephrogenic systemic fibrosis (NSF), and other rare conditions which only impact a few hundred or a few thousand people, may experience difficulty obtaining insurance coverage for treatments which could improve their condition. Insurers often refuse to pay for treatments they consider "experimental"… Read More
An article in the current issue of the New England Journal of Medicine offers an explanation why gadolinium based MRI contrast agents may cause Nephrogenic Systemic Fibrosis (NSF) in those with kidney insufficiencies. NSF has been directly linked to the use of gadolinium, and it has… Read More
The latest edition of the FDA Patient Safety News webcast features a segment about the dangers of MRI contrast agents containing gadolinium. For individuals with kidney failure, the MRI contrast dyes could lead to a serious condition called nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing demopathy… Read More
Since magnetic resonance imaging (MRI) was first introduced in the 1980s, it has become a widely used diagnostic tool. In many cases a contrast agent is administered before the test to allow the physicians to differentiate blood vessels from nearby tissue. However, for those with kidney… Read More
High-resolution heart CT scans used to diagnose blocked arteries and heart disease could increase the risk of cancer, according to a new study published in the Journal of the American Medical Association. The 64-slice heart scans, known as a computer tomography (CT) coronary angiography, use high levels… Read More
The American College of Radiology (ACR) issued an update to their 2004 guidelines on MRI safety, called the ACR Guidance Document for Safe MR Practices. A section of the document is devoted to discussing the risk of Nephrogenic Systemic Fibrosis (NSF), also known as Nephrogenic Fibrosing… Read More
At Saiontz & Kirk, P.A., our lawyers are reviewing potential lawsuits for individuals who have been diagnosed with Nephrogenic Systemic Fibrosis, which has been directly linked to gadolinium-based contrast dyes used during MRI and MRA scans. Many people have contacted our office expressing concerns about the… Read More
Since our law firm began representing individuals who developed Nephrogenic Systemic Fibrosis after receiving an MRI or MRA with contrast, we have spoken with many concerned individuals with serious skin problems who have not been diagnosed with the rare condition. Even without a diagnosis, our lawyers… Read More
Today the FDA requested that a black box warning be added to MRI contrast agents which are gadolinium-based. For those with kidney problems, an MRA or MRI with contrast could lead to a debilitating and potentially fatal condition known as nephrogenic systemic fibrosis (NSF). Problems with… Read More
